Voxelwise and Patientwise Correlation of 18F-FDOPA PET, Relative Cerebral Blood Volume, and Apparent Diffusion Coefficient in Treatment-Naïve Diffuse Gliomas with Different Molecular Subtypes
- PMID: 32646876
- PMCID: PMC8049346
- DOI: 10.2967/jnumed.120.247411
Voxelwise and Patientwise Correlation of 18F-FDOPA PET, Relative Cerebral Blood Volume, and Apparent Diffusion Coefficient in Treatment-Naïve Diffuse Gliomas with Different Molecular Subtypes
Abstract
Our purpose was to identify correlations between 18F-fluorodihydroxyphenylalanine (18F-FDOPA) uptake and physiologic MRI, including relative cerebral blood volume (rCBV) and apparent diffusion coefficient (ADC), in gliomas with different molecular subtypes and to evaluate their prognostic values. Methods: Sixty-eight treatment-naïve glioma patients who underwent 18F-FDOPA PET and physiologic MRI were retrospectively selected (36 with isocitrate dehydrogenase wild-type [IDHwt], 16 with mutant 1p/19q noncodeleted [IDHm-noncodel], and 16 with mutant codeleted [IDHm-codel]). Fluid-attenuated inversion recovery hyperintense areas were segmented and used as regions of interest. For voxelwise and patientwise analyses, Pearson correlation coefficients (rvoxelwise and rpatientwise) between the normalized SUV (nSUV), rCBV, and ADC were evaluated. Cox regression analysis was performed to investigate the associations between overall survival and rvoxelwise, maximum or median nSUV, median rCBV, or median ADC. Results: For IDHwt and IDHm-noncodel gliomas, nSUV demonstrated significant positive correlations with rCBV (rvoxelwise = 0.25 and 0.31, respectively; rpatientwise = 0.50 and 0.70, respectively) and negative correlations with ADC (rvoxelwise = -0.19 and -0.19, respectively; rpatientwise = -0.58 and -0.61, respectively) in both voxelwise and patientwise analyses. IDHm-codel gliomas demonstrated a significant positive correlation between nSUV and ADC only in voxelwise analysis (rvoxelwise = 0.18). In Cox regression analysis, rvoxelwise between nSUV and rCBV (hazard ratio, 28.82) or ADC (hazard ratio, 0.085) had significant associations with overall survival for only IDHwt gliomas. Conclusion: IDHm-codel gliomas showed distinctive patterns of correlations between amino acid PET and physiologic MRI. Stronger correlations between nSUV and rCBV or ADC may result in a worse prognosis for IDHwt gliomas.
Keywords: 18F-FDOPA PET; ADC; correlation coefficient; glioma; rCBV.
© 2021 by the Society of Nuclear Medicine and Molecular Imaging.
Figures





Similar articles
-
Relationship Between [18F]FDOPA PET Uptake, Apparent Diffusion Coefficient (ADC), and Proliferation Rate in Recurrent Malignant Gliomas.Mol Imaging Biol. 2015 Jun;17(3):434-42. doi: 10.1007/s11307-014-0807-3. Mol Imaging Biol. 2015. PMID: 25465392
-
Maximum Uptake and Hypermetabolic Volume of 18F-FDOPA PET Estimate Molecular Status and Overall Survival in Low-Grade Gliomas: A PET and MRI Study.Clin Nucl Med. 2020 Dec;45(12):e505-e511. doi: 10.1097/RLU.0000000000003318. Clin Nucl Med. 2020. PMID: 33031233 Free PMC article.
-
Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign.Eur Radiol. 2020 Feb;30(2):844-854. doi: 10.1007/s00330-019-06395-2. Epub 2019 Aug 24. Eur Radiol. 2020. PMID: 31446467
-
Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas.Neuroimage Clin. 2018 Jul 5;20:51-60. doi: 10.1016/j.nicl.2018.07.001. eCollection 2018. Neuroimage Clin. 2018. PMID: 30069427 Free PMC article. Review.
-
The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance.Neurosurg Focus. 2019 Dec 1;47(6):E13. doi: 10.3171/2019.9.FOCUS19660. Neurosurg Focus. 2019. PMID: 31786548
Cited by
-
Comparison of Amino Acid PET to Advanced and Emerging MRI Techniques for Neurooncology Imaging: A Systematic Review of the Recent Studies.Mol Imaging. 2021 Jan 20;2021:8874078. doi: 10.1155/2021/8874078. eCollection 2021. Mol Imaging. 2021. PMID: 34194287 Free PMC article.
-
Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PET.Cancer Imaging. 2021 Mar 10;21(1):27. doi: 10.1186/s40644-021-00396-5. Cancer Imaging. 2021. PMID: 33691798 Free PMC article.
-
PET Imaging in Neuro-Oncology: An Update and Overview of a Rapidly Growing Area.Cancers (Basel). 2022 Feb 22;14(5):1103. doi: 10.3390/cancers14051103. Cancers (Basel). 2022. PMID: 35267411 Free PMC article. Review.
-
Exploring the mechanism of 18F-fluorodopa uptake in recurrent high-grade gliomas: A comprehensive histomolecular-positron emission tomography analysis.Eur J Neurol. 2024 Jan;31(1):e16093. doi: 10.1111/ene.16093. Epub 2023 Oct 12. Eur J Neurol. 2024. PMID: 37823694 Free PMC article.
-
Combining 18F-DOPA PET and MRI with perfusion-weighted imaging improves delineation of high-grade subregions in enhancing and non-enhancing gliomas prior treatment: a biopsy-controlled study.J Neurooncol. 2021 Dec;155(3):287-295. doi: 10.1007/s11060-021-03873-w. Epub 2021 Oct 22. J Neurooncol. 2021. PMID: 34686993
References
-
- Galldiks N, Lohmann P, Cicone F, Langen KJ. FET and FDOPA PET imaging in glioma. In: Pope W, ed. Glioma Imaging. Springer; 2019:211–222.
-
- Deuschl C, Kirchner J, Poeppel TD, et al. . 11C-MET PET/MRI for detection of recurrent glioma. Eur J Nucl Med Mol Imaging. 2018;45:593–601. - PubMed
-
- Rahm V, Boxheimer L, Bruehlmeier M, et al. . Focal changes in diffusivity on apparent diffusion coefficient MR imaging and amino acid uptake on PET do not colocalize in nonenhancing low-grade gliomas. J Nucl Med. 2014;55:546–550. - PubMed